P A Ory

Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: Results of a double‐blind, randomized, placebo‐controlled trial

Philip J. Mease, Dafna D. Gladman, Christopher T. Ritchlin et al. · Arthritis & Rheumatism · 2005 · 899 citations

Etanercept treatment of psoriatic arthritis: Safety, efficacy, and effect on disease progression

Philip J. Mease, Alan Kivitz, Francis X. Burch et al. · Arthritis & Rheumatism · 2004 · 882 citations

Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: A twelve‐month, multicenter, randomized, double‐blind, placebo‐controlled, phase II clinical trial

Stanley Cohen, Robin K. Dore, Nancy E. Lane et al. · Arthritis & Rheumatism · 2008 · 564 citations

Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept

D. van der Heijde, Robert Landewé, Steven Einstein et al. · Arthritis & Rheumatism · 2008 · 545 citations

Adalimumab for long‐term treatment of psoriatic arthritis: Forty‐eight week data from the adalimumab effectiveness in psoriatic arthritis trial

Dafna D. Gladman, Philip J. Mease, Christopher T. Ritchlin et al. · Arthritis & Rheumatism · 2007 · 296 citations